RFL Stock Price Chart
RFL Earnings
Rafael Holdings Inc
$2.33
9.9%
$0.2
As of today:Jun 12, 11:39:52 GMT-4
Back
Rafael Holdings Inc (RFL) Earnings
Latest Earnings Results: Q1 '25
Reported: 2024-12-11
Historical Earnings
Quarterly
Annual
EPS
Revenue
Earnings FAQ
How did RFL's recent EPS compare to expectations?
How did Rafael Holdings Inc RFL's revenue perform in the last quarter?
What is the revenue estimate for Rafael Holdings Inc?
What's the earning quality score for Rafael Holdings Inc?
When does Rafael Holdings Inc report earnings?
What are Rafael Holdings Inc's expected earnings?
Did Rafael Holdings Inc beat earnings expectations?
Key Stats
Prev.Close
$2.12
Open
$2.16
Day's Range
$2.16 - $2.5
52 week range
$1.12 - $3.19
Volume
693.5K
Avg.Volume
77.6K
Dividend yield
--
EPS (TTM)
-0.78
Market Cap
$121.1M
What is RFL?
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 21 full-time employees. The company went IPO on 2018-03-12. The firm's segments include Healthcare, Infusion Technology and Real Estate. The Company’s lead candidate is Trappsol Cyclo, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal and progressive genetic disorder. The Healthcare segment comprises equity interests in LipoMedix Pharmaceuticals Ltd., Barer Institute Inc., Cornerstone Pharmaceuticals, Inc., Cyclo, and Rafael Medical Devices, LLC. The Real Estate segment consists of the Company’s real estate holdings, which comprise a portion of one commercial building in Israel. The Infusion Technology segment comprises equity interests in Day Three Labs, Inc. LipoMedix Pharmaceuticals Ltd. is a clinical-stage pharmaceutical company.
